Ruxolitinib Cream for Vitiligo | NEJM

Treatments for repigmentation of vitiligo skin lesions are lacking. A phase 2 trial previously showed promise for ruxolitinib cream, but additional data were needed. New research findings are summarized in a short video. To see the full article, follow this link: https://nej.md/3es7Lzf